• No results found

University of Groningen Interplay between dietary fibers and gut microbiota for promoting metabolic health Mistry, Rima

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Interplay between dietary fibers and gut microbiota for promoting metabolic health Mistry, Rima"

Copied!
3
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Interplay between dietary fibers and gut microbiota for promoting metabolic health Mistry, Rima

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date: 2019

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Mistry, R. (2019). Interplay between dietary fibers and gut microbiota for promoting metabolic health. University of Groningen.

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

137

BIOGRAPHY

The author of this thesis, Rima Mistry was born on July 24th, 1988 in Dar es Salaam, Tanzania. After completion of her secondary education in 2008 in Dar es Salaam, she was selected for bachelor’s degree program in Biochemistry and Cell Biology at Jacobs University Bremen (Germany). During her studies, she obtained her first exposure to cutting-edge research in life science with international experience. In 2011, she received a scholarship to pursue Top master’s research program in Medical and Pharmaceutical Drug Innovation at the University of Groningen (The Netherlands). She performed two master’s thesis, one in the Department of Pharmaceutical Biology under the supervision of Prof. Dr. Wim Quax and one in the Department of Experimental Hematology under the supervision of Prof. Dr. Jan Jacob Schuringa. At the end of 2013, she received her master’s degree. In April 2014, she started her PhD at the Department of Pediatrics of University Medical Center Groningen. In her research, she studied the effects of various dietary fibers on metabolic health under the supervision of Prof. Dr. Henkjan Verkade and Dr. Uwe Tietge. Results of her work are described in this thesis.

(3)

Referenties

GERELATEERDE DOCUMENTEN

The work described in this thesis is performed at the Department of Pediatrics, Center for Liver, Digestive, and Metabolic Diseases, University of Groningen, University Medical

Interplay between dietary fibers and gut microbiota for promoting metabolic health Intestine Liver Cholesterol Conjugated Bile acids De novo synthesis Lipoprotein

(A) biliary cholesterol secretion; (B) total fecal neutral sterol (NS) excretion; (C) intestinal fractional cholesterol absorption; (D) trans-intestinal cholesterol efflux (TICE)..

Beta diversity analysis with both, weighted and unweighted unifrac distances, as well as genus level relative abundance based RDA analysis (Fig. 2B) all showed that

Biliary secretion of cholesterol (2-fold, P<0.001) and bile acids (3-fold, P<0.001) was substantially increased in the germ-free model, while fecal neutral sterol excretion

The present study characterized the impact of dietary ß-cyclodextrin (ßCD, 10%, w/w), a cyclic oligosaccharide, on sterol metabolism and reverse cholesterol transport (RCT)

(A) body weight gain; (B) food intake at the end of the dietary intervention; (C) fat mass; (D) adipose fat depots; (E) glucose tolerance test (GTT) performed at the end of

An increase of microbial richness is a potential biomarker for defining response to vedolizumab treatment in patients with inflammatory bowel disease (This thesis) 8.